• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12G filed by GreenLight Biosciences Holdings PBC

    8/11/23 9:00:27 AM ET
    $GRNA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $GRNA alert in real time by email
    15-12G 1 d526750d1512g.htm 15-12G 15-12G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 15

     

     

    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

    UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

    OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934.

    Commission File Number 001-39894

     

     

    GreenLight Biosciences Holdings, PBC

    (Exact name of registrant as specified in its charter)

     

     

    29 Hartwell Avenue

    Lexington, Massachusetts 02421

    (617) 616-8188

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

    Common Stock, par value $0.0001 per share

    Warrants, each exercisable for one share of Common Stock for $11.50 per share

    (Title of each class of securities covered by this Form)

    None

    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

     

     

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     

    Rule 12g-4(a)(1)

      ☒

    Rule 12g-4(a)(2)

      ☐

    Rule 12h-3(b)(1)(i)

      ☒

    Rule 12h-3(b)(1)(ii)

      ☐

    Rule 15d-6

      ☐

    Rule 15d-22(b)

      ☐

    Approximate number of holders of record as of the certification or notice date: Common Stock: 1

                                                                                                   Warrants: 569

     

     

     


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, GreenLight Biosciences Holdings, PBC has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

     

        GREENLIGHT BIOSCIENCES HOLDINGS, PBC
    Date: August 11, 2023     By:  

    /s/ Nina Thayer

          Nina Thayer
    General Counsel, Chief Compliance Officer & Corporate Secretary
    Get the next $GRNA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GRNA

    DatePrice TargetRatingAnalyst
    12/8/2022$4.00Buy
    Canaccord Genuity
    10/14/2022$5.50Outperform
    Credit Suisse
    More analyst ratings

    $GRNA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • GreenLight Announces Completion of Merger with Fall Line Endurance Fund

      LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) ("GreenLight" or the "Company") today announced the closing of its previously announced merger with SW MergerCo, Inc. ("Merger Sub") and SW ParentCo, Inc. ("Parent"), pursuant to which Merger Sub merged with and into GreenLight with GreenLight surviving as a wholly-owned subsidiary of Parent (the "Merger"). Following the completion of the Merger, shares of GreenLight common stock, par value $0.0001 per share, and GreenLight warrants ceased trading on the NASDAQ Global Market (the "NASDAQ") before market open on July 24, 2023, and will no longer be listed for trading on the NASDAQ. Each r

      7/24/23 9:49:15 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares

      LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) ("GreenLight" or the "Company") today announced that it is initiating the final steps in closing its previously announced merger with SW MergerCo, Inc. ("Merger Sub") and SW ParentCo, Inc ("Parent"). Following the completion of the Merger, shares of GreenLight common stock are expected to cease trading on the NASDAQ Global Market ("NASDAQ") after market close on July 20, 2023, and will no longer be listed for trading on the NASDAQ. Merger Sub's tender offer (the "Offer") to purchase any and all outstanding shares of GreenLight's common stock (other than shares of GreenLight common stock (

      7/20/23 8:06:08 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lifshitz Law PLLC Announces Investigations of GRNA, AAIC, EMBK, and REUN

      NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of GRNA to a group of buyers led by Fall Line Capital, LLC for $0.30 per share in cash. If you are a GRNA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected]. Arlington Asset Investment Corp. (NYSE:AAIC) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connect

      6/3/23 8:17:00 PM ET
      $AAIC
      $EMBK
      $GRNA
      $REUN
      Real Estate Investment Trusts
      Real Estate
      Computer Software: Prepackaged Software
      Technology

    $GRNA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Kodiak Venture Partners Iii Lp

      4 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

      7/27/23 10:55:29 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 3: New insider Kodiak Venture Partners Iii Lp claimed ownership of 9,809,895 shares

      3 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

      7/27/23 10:48:26 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Clarke Dennis A.

      4 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

      7/27/23 10:25:48 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $GRNA
    Financials

    Live finance-specific insights

    See more
    • GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares

      LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) ("GreenLight" or the "Company") today announced that it is initiating the final steps in closing its previously announced merger with SW MergerCo, Inc. ("Merger Sub") and SW ParentCo, Inc ("Parent"). Following the completion of the Merger, shares of GreenLight common stock are expected to cease trading on the NASDAQ Global Market ("NASDAQ") after market close on July 20, 2023, and will no longer be listed for trading on the NASDAQ. Merger Sub's tender offer (the "Offer") to purchase any and all outstanding shares of GreenLight's common stock (other than shares of GreenLight common stock (

      7/20/23 8:06:08 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $GRNA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $GRNA
    SEC Filings

    See more
    • Canaccord Genuity initiated coverage on GreenLight Biosciences with a new price target

      Canaccord Genuity initiated coverage of GreenLight Biosciences with a rating of Buy and set a new price target of $4.00

      12/8/22 9:11:51 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Credit Suisse initiated coverage on GreenLight Biosciences with a new price target

      Credit Suisse initiated coverage of GreenLight Biosciences with a rating of Outperform and set a new price target of $5.50

      10/14/22 7:27:11 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 15-12G filed by GreenLight Biosciences Holdings PBC

      15-12G - GreenLight Biosciences Holdings, PBC (0001822691) (Filer)

      8/11/23 9:00:27 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • GreenLight Biosciences Holdings PBC filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (Amendment)

      8-K/A - GreenLight Biosciences Holdings, PBC (0001822691) (Filer)

      7/28/23 9:02:32 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form EFFECT filed by GreenLight Biosciences Holdings PBC

      EFFECT - GreenLight Biosciences Holdings, PBC (0001822691) (Filer)

      7/26/23 12:15:07 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $GRNA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by GreenLight Biosciences Holdings PBC (Amendment)

      SC 13D/A - GreenLight Biosciences Holdings, PBC (0001822691) (Subject)

      7/28/23 4:25:26 PM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D/A filed by GreenLight Biosciences Holdings PBC (Amendment)

      SC 13D/A - GreenLight Biosciences Holdings, PBC (0001822691) (Subject)

      7/28/23 10:54:08 AM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D/A filed by GreenLight Biosciences Holdings PBC (Amendment)

      SC 13D/A - GreenLight Biosciences Holdings, PBC (0001822691) (Subject)

      7/27/23 4:24:26 PM ET
      $GRNA
      Biotechnology: Pharmaceutical Preparations
      Health Care